AlphaQuest LLC Reduces Position in Maximus, Inc. (NYSE:MMS)

AlphaQuest LLC lessened its holdings in shares of Maximus, Inc. (NYSE:MMS) by 94.5% during the 4th quarter, HoldingsChannel reports. The fund owned 2,060 shares of the health services provider’s stock after selling 35,428 shares during the quarter. AlphaQuest LLC’s holdings in Maximus were worth $154,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also modified their holdings of the business. UMB Bank n.a. boosted its stake in shares of Maximus by 79.8% during the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock worth $27,000 after acquiring an additional 158 shares during the last quarter. V Square Quantitative Management LLC lifted its stake in shares of Maximus by 65.9% during the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock valued at $34,000 after buying an additional 180 shares in the last quarter. Petrus Trust Company LTA lifted its stake in shares of Maximus by 2.7% during the 3rd quarter. Petrus Trust Company LTA now owns 7,084 shares of the health services provider’s stock valued at $660,000 after buying an additional 185 shares in the last quarter. Holocene Advisors LP lifted its stake in shares of Maximus by 6.5% during the 3rd quarter. Holocene Advisors LP now owns 3,927 shares of the health services provider’s stock valued at $366,000 after buying an additional 239 shares in the last quarter. Finally, MML Investors Services LLC lifted its stake in shares of Maximus by 6.5% during the 3rd quarter. MML Investors Services LLC now owns 4,870 shares of the health services provider’s stock valued at $454,000 after buying an additional 299 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Wall Street Analyst Weigh In

MMS has been the topic of a number of analyst reports. StockNews.com cut shares of Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price on the stock in a research note on Thursday, January 2nd.

Insider Transactions at Maximus

In other news, insider Ilene R. Baylinson sold 14,500 shares of the company’s stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the sale, the insider now owns 2,512 shares of the company’s stock, valued at approximately $171,167.68. This represents a 85.23 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.60% of the company’s stock.

Maximus Stock Performance

Maximus stock opened at $67.99 on Tuesday. The company’s 50-day moving average price is $71.83 and its 200-day moving average price is $79.13. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. The company has a market cap of $3.85 billion, a PE ratio of 14.62 and a beta of 0.71.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, equities research analysts forecast that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Saturday, February 15th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.76%. Maximus’s payout ratio is presently 25.81%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.